PubMed · 6236170
The source did not provide an abstract. Follow the original record for more information.
Explore connections, maps & timelines
1983. [Proctology].. https://pubmed.ncbi.nlm.nih.gov/6236170/
Cite the original work for its findings. Save a collection to share your selection of sources.
KEEP EXPLORING
It was aimed to determine the normal hair scores of women of Kirikkale region according to the Ferriman- Gallwey scale and to investigate the relationship between the hair shaft diameter and hair scores. Hair scores were calculated in 204 healthy women, and hair shaft diameters were measured from the hair samples collected from 60 patients. Body mass index, waist to hip ratio, insulin resistance and blood androgen levels were determined. Neutral, hormonal and total hair scores were 2.1 1.4, 3.1 2.7 and 5.2 3.6, respectively. The average total hair diameter and hormonal hair diameter were 191.93 90.49 m and 121.8 75.9 m respectively. The correlation between total hair diameter and total hair score was statistically significant (r=0.704 p 0.001). Also, the correlation between hormonal hair diameter and hormonal hair score was statistically significant (r=0.724 p 0.001). While hair scores and diameters show meaningful positive correlation with androgen levels, they show negative correlation with age. In our population, 95% value of total hair score was 11, and for the hormonal score, it was 9. Hair diameters increase with hair score, regardless of total or hormonal of hair scores. Hair scores and hair diameters may be affected by blood androgens in healthy women.
Explore the source record for details and available documents.
The authors report seven patients from six neuro-ophthalmology referral centers who developed pseudo-tumor cerebri during treatment with doxycycline. All four female patients and one of three male patients were obese. Vision was minimally affected in most patients, but two had substantial visual acuity or visual field loss at presentation. Discontinuation of doxycycline, with or without additional intracranial pressure-lowering agents, yielded improvement, but permanent visual acuity or visual field loss occurred in five patients.